603590 康辰藥業
按盤價 
40.460 -0.300 (-0.736%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.033 | 1.361 | 5.027 | 3.491 | 4.960 |
| 總資產報酬率 ROA (%) | 3.210 | 1.096 | 4.176 | 2.987 | 4.135 |
| 投入資產回報率 ROIC (%) | 3.698 | 1.271 | 4.842 | 3.426 | 4.828 | 邊際利潤分析 |
| 銷售毛利率 (%) | 90.153 | 89.566 | 89.017 | 85.444 | 86.940 |
| 營業利潤率 (%) | 23.296 | 4.736 | 15.574 | 16.234 | 23.746 |
| 息稅前利潤/營業總收入 (%) | 21.460 | 4.063 | 12.095 | 14.129 | 20.433 |
| 淨利潤/營業總收入 (%) | 19.402 | 2.609 | 20.388 | 14.295 | 20.677 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 106.217 | 332.345 | 119.224 | 99.259 | 72.601 |
| 價值變動淨收益/利潤總額(%) | 6.797 | 45.430 | 3.825 | -5.450 | 18.873 |
| 營業外收支淨額/利潤總額(%) | -8.806 | -0.577 | -16.744 | -0.276 | -1.820 | 償債能力分析 |
| 流動比率 (X) | 3.121 | 3.081 | 3.803 | 5.899 | 6.124 |
| 速動比率 (X) | 2.985 | 2.876 | 3.653 | 5.684 | 5.820 |
| 資產負債率 (%) | 13.917 | 12.591 | 11.067 | 6.852 | 7.141 |
| 帶息債務/全部投入資本 (%) | 6.954 | 4.847 | 4.093 | -0.584 | -0.715 |
| 股東權益/帶息債務 (%) | 1,307.339 | 1,907.741 | 2,304.434 | -16,868.760 | -13,673.838 |
| 股東權益/負債合計 (%) | 567.408 | 637.133 | 731.277 | 1,246.789 | 1,199.940 |
| 利息保障倍數 (X) | 436.110 | -6.292 | -9.710 | -6.856 | -7.073 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 111.404 | 112.304 | 105.785 | 106.064 | 90.845 |
| 存貨周轉天數 (天) | 260.803 | 252.574 | 152.229 | 119.869 | 137.797 |
| 備註： | 即時報價更新時間為 25/12/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
